🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

I‐Hsuan Su

University of North Carolina at Chapel Hill

ORCID: 0000-0002-2916-4397

Also affiliated with Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (Sweden)

MedicineEconomics, Econometrics and FinanceMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Regarding “Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs””.

Regarding “Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs”

The Oncologist(2023)10.1093/oncolo/oyad130
N/A
0DataRank · unranked
4 citations

Jennifer L. Lund, Charles Gaber, Hanna K. Sanoff, Paula D. Strassle, Emilie D. Duchesneau +1 more

Prevalence of Lung Cancer Screening in the US, 2022

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.3190
N/A
0DataRank · unranked
110 citations

I‐Hsuan Su, M. Patricia Rivera, Joyce Pak, Xiaomeng Chen, Daniel S. Reuland +2 more

Use of sensitivity analyses to assess uncontrolled confounding from unmeasured variables in observational, active comparator pharmacoepidemiologic studies: a systematic review

American Journal of Epidemiology(2024)10.1093/aje/kwae234
N/A
0DataRank · unranked
9 citations

Megan Delgado, I‐Hsuan Su, Catherine Wiener, Clement O Acheampong, Charles Poole +9 more

Prevalence of Lung Cancer Screening in the US, 2022

UNC Libraries(2024)10.17615/v13h-xv23
N/A
0DataRank · unranked
0 citations

M. Patricia Rivera, I‐Hsuan Su, Joyce Pak, Xiaomeng Chen, Daniel S. Reuland +2 more